ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX06 | B | Pomalidomide - 4mg | 11549/388 | 146721/1 | IMNOVID | 4mg | 21 | Capsule, hard | Oral | Droguerie de l'Union | Celgene International SARL | Switzerland | L.L | 2.44 | E2 | Bristol-Myers Squibb Pharma EEIG | Ireland | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX06 | B | Pomalidomide - 4mg | 11549 | 146721/1 | IMNOVID | 4mg | 21 | Capsule, hard | Oral | Droguerie de l'Union | Celgene International SARL | Switzerland | 662,450,757 L.L | 2.44 | E2 | Bristol-Myers Squibb Pharma EEIG | Ireland | 2/5/2024 | 0 |